Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

The oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 revealed a manageable safety profile in relapsed ...

Researchers conducted a retrospective study published in July 2025 issue of Journal of Hematology & Oncology to examine the ...

YourChoice Therapeutics, working with Quotient Sciences and Incyte, reports that single oral doses of the investigational non ...

Participants who are enrolled will be given a dose of ADI-001, followed by a 28-day dose-limiting toxicity window.

A wearable technology developed by Technion Professor Hossam Haick and colleagues in China enables real-time, noninvasive ...

Find the latest Certara, Inc. (CERT) stock quote, history, news and other vital information to help you with your stock trading and investing.

EMA encourages NAMs to replace animal testing, aligning with 3Rs principles, and has published a concept paper on regulatory ...

Presentation to highlight the Company’s proprietary protein-misfolding platform, EpiSelectTM, used to develop PMN310 ...

IPF treatment candidate CS014 was safe and well tolerated in volunteers in a Phase 1 trial, and showed early promise for ...

In July 2025, CSL Behring conducted a study in China is to investigate the pharmacokinetics (PK) of rVIII-SingleChain after ...